Adalimumab-induced pulmonary sarcoidosis not progressing upon treatment with etanercept.

Jung, J H; Kim, J-H; Song, G G

Jung, J H; Kim, J-H; Song, G G.

Affiliation

Jung JH; Korea University College of Medicine, Seoul, Korea.
Kim JH; Division of Rheumatology, Department of Internal Medicine, Korea University Guro Hospital, 148, Gurodong-ro, Guro-gu, 08308, Seoul, Korea.
Song GG; Korea University College of Medicine, Seoul, Korea.

Z Rheumatol ; 76(4): 372-374, 2017 May.

Article in En | MEDLINE | ID: mdl-28124746

Subject(s)

Adalimumab/adverse effects; Etanercept/therapeutic use; Sarcoidosis, Pulmonary/chemically induced; Sarcoidosis, Pulmonary/drug therapy; Adult; Disease Progression; Drug Substitution/adverse effects; Drug Substitution/methods; Humans; Male; Sarcoidosis, Pulmonary/diagnosis; Treatment Outcome

Key words

Adalimumab; Etanercept; Paradoxical response; Pulmonary sarcoidosis; Tumor necrosis factor-α

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sarcoidosis, Pulmonary / Adalimumab / Etanercept Type of study: Diagnostic_studies Limits: Adult / Humans / Male Language: En Journal: Z Rheumatol Year: 2017 Document type: Article

Fulltext

XML

PubMed Links

Search on Google